Enzyme Finance vs Reserve Protocol: funds or baskets? (2026)

Enzyme and Reserve both turn baskets or strategies into on-chain products, but they solve different problems. Enzyme combines tools for issuing and administering tokenized funds with strategy-management infrastructure. Onyx targets fund issuers, while Blue supports managers running decentralized strategies across more than 30 protocols and hundreds of assets. Myso adds on-chain options. Reserve focuses on DTFs: tokens representing baskets whose assets can be weighted and rebalanced according to stated rules. It offers both Index and Yield DTF categories, plus permissionless creation. Choose Enzyme if you need fund infrastructure, management tools, or white-label options. Choose Reserve if you want a more direct index-style basket product or want to create a DTF.

Enzyme lists Ethereum, Polygon, and Arbitrum, while Reserve lists Ethereum, Base, BNB Chain, and Arbitrum. Both support Ethereum and Arbitrum, but their other listed chains differ. Enzyme reports about $94 million in TVL; Reserve reports about $48 million. These figures indicate the relative amount of value held in each protocol, but do not establish investment performance or safety. Enzyme’s product set is broader, with fund issuance, managed strategies, and options described. Reserve’s offering is more focused on tokenized baskets, including themes such as AI, robotics, and the Magnificent 7. Those baskets can carry concentrated sector exposure, so check their composition and rules. Both platforms have active status and list the same number of audits, though audit details are not published.

Neither project publishes specific fee levels in these descriptions, so you should not assume either is cheaper. Enzyme directs Onyx issuers to a pricing page, but the exact pricing is not stated here. Vault managers may set management or performance fees, and each vault’s terms should be checked before depositing. Network gas fees also apply. Reserve has a dedicated Fees page for Index DTFs, but minting, redemption, and management fee levels are not stated here either. Its access-venue comparison describes venue costs rather than protocol fees, and exchange spreads and network gas can add costs. For either platform, review the current product terms and transaction costs before using it. Fee uncertainty is especially relevant when comparing a managed fund with a DTF, since their charging structures may differ.

Both protocols have two audits listed, but neither publishes auditor names, audit scope, dates, or findings here. Enzyme says it has SOC 2 certification and cites more than eight years of operation; those points do not remove the risks of smart contracts, a manager’s strategy, or the third-party protocols a vault uses. Reserve also carries smart-contract risk, as well as possible oracle or pricing problems and decisions made through RSR governance. In either case, an audit listing is not a guarantee against loss. Enzyme’s compliance tools, such as whitelisting and transaction monitoring, do not make an issuer’s fund compliant by themselves. Reserve’s operator says it is not a bank, broker-dealer, or registered financial adviser. Check relevant rules and product risks before participating.

Pick Enzyme if you are an issuer or asset manager looking for tools to create and administer tokenized funds, embed products through APIs or SDKs, or manage decentralized strategies. Its institutional orientation and Onyx tooling make it the more natural fit for that work, though pricing and product-specific track records should be checked. Pick Reserve if your priority is a rules-based tokenized basket, access to themed DTFs, or permissionless DTF creation and governance by RSR holders. Its product is more straightforward to understand as an index-style basket, but newer baskets may have limited performance history, and their sector concentration can be significant. If you are an individual choosing between the two, Reserve is the clearer basket product; Enzyme is better suited to managed funds and strategy infrastructure.